Author(s): Lehmacher W, Wassmer G
Abstract Share this page
Abstract A method for group sequential trials that is based on the inverse normal method for combining the results of the separate stages is proposed. Without exaggerating the Type I error rate, this method enables data-driven sample size reassessments during the course of the study. It uses the stopping boundaries of the classical group sequential tests. Furthermore, exact test procedures may be derived for a wide range of applications. The procedure is compared with the classical designs in terms of power and expected sample size.
This article was published in Biometrics
and referenced in Pharmaceutica Analytica Acta